Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-044536

Chief Innovation/Tech Officer gave up 7,177 shares (to pay taxes)

  • Chief Innovation/Tech Officer acquired 14,572 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schobel Alexander Mark · Chief Innovation/Tech Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-30 Exercise or conversion : show line 1 in the form +14,572 1,023,801 D
2018-11-30 Shares withheld for taxes : show line 2 in the form −7,177 $8.59 $61,650 1,016,624 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-11-30 Exercise or conversion : show line 3 in the form Restricted Stock Unit −14,572 87,432 D
Loading xslF345X03/form4.xml…